TechAccel

TechAccel (Technology Acceleration Partners) is a Kansas City-area technology and venture development organization founded in 2014 by Michael Helmstetter together with Kansas State University and the Bicknell Family Holding Company. It describes itself as a first-of-its-kind hybrid that pairs equity capital with R&D: its 'Equity+ Science Advancement' model invests in startups and simultaneously funds research at universities and partners to bridge the gap between scientific discovery and commercialization. The firm focuses on agriculture (agtech), animal health and nutrition, and food technology, sectors its leadership argues are under-appreciated by mainstream venture capital that concentrates on human health. Rather than operating as a conventional pooled fund, TechAccel is an operating company backed by Kansas City-based high-net-worth individuals and family offices, calling capital as needed to fund specific projects; individual investments typically range from about $500,000 to $1 million, and it generally invests as a co-investor. It is led by Co-Founder, President and CEO Dr. Michael Helmstetter, who brings more than 30 years of startup, spin-off and technology-advancement experience across agriculture, defense and biotechnology. TechAccel's portfolio of roughly a dozen disclosed companies has produced one IPO, GreenLight Biosciences, and one acquisition, Agrivida, and includes investments such as Benson Hill Biosystems, where it joined a $25M Series B in crop science, and Epicrop Technologies, a crop-epigenetics company. It also co-formed Covenant Animal Health Partners, later sold to NovaQuest Capital Management in 2021. By coupling equity investment with funded science advancement, TechAccel backs agriculture, animal-health and food-technology innovation from discovery through commercialization.